Chris M. Kolber Joins Linden as Operating Partner

November 10, 2011 | For Immediate Release

Former Hospira and Abbott Executive Expands Private Equity Firm’s Operating Expertise

CHICAGO, Illinois, (November 10, 2011) – Linden Capital Partners, a Chicago-based private equity firm that focuses on middle market leveraged buyout investments in the healthcare sector, today announced the addition of Chris M. Kolber as an operating partner.

Mr. Kolber was a member of the Hospira executive team in the 2004 spin out from Abbott Laboratories and recently served as president, Global Devices, a $1 billion segment of Hospira’s business. He is a 30-year veteran of the healthcare industry with extensive experience in the medical products and specialty and generic pharmaceutical sectors. Prior to Hospira, Mr. Kolber spent 25 years at Abbott Laboratories in various general management and corporate development roles including division vice president of licensing and new business development. Mr. Kolber began his career in the Hospital Products division of Abbott and was instrumental in the development of Abbott’s Drug and Drug Delivery Systems business.

Mr. Kolber augments Linden’s group of operating partners who collectively have more than a century of healthcare experience. He will work closely with Linden’s investment team to source and perform due diligence on new opportunities as well as to support existing portfolio companies.